Tongue Cancer Completed Phase 1 / 2 Trials for INGN 201 (DB05322)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00064103Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or PharynxPrevention